Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1566 results
Halozyme, Janssen to develop and commercialize products using Enhanze technology
By PBR Staff Writer
US-based biopharmaceutical firm Halozyme Therapeutics has entered into a worldwide collaboration and license agreement with Janssen Biotech to develop and commercialize products combining Janssen compounds with Halozyme's Enhanze technology.
Automation > IT & Software > News
Portage further validates new proprietory cell permeable peptide platform technology
Portage Biotech, is pleased to announce that its wholly owned subsidiary Portage Pharmaceuticals has further validated its platform cell penetrating peptide technology for safely delivering a potent anti-inflammatory cargo into eye tissues.
Automation > IT & Software > News
PPD, ERT partner to improve drug development
Pharmaceutical Product Development, and ERT announced a strategic partnership to facilitate delivery of ERT’s comprehensive solutions for patient safety and efficacy endpoint data collection to help biopharmaceutical clients conduct clinical trials in a more efficient and cost-effective manner.
Automation > IT & Software > News
X-Chem, Alexion to discover new therapies for severe and ultra-rare disorders
By PBR Staff Writer
US-based biotechnology firm X-Chem has entered into a drug discovery collaboration with Alexion (ALXN) for new therapies to treat patients with severe and ultra-rare disorders.
Automation > IT & Software > News
Pieris begins Phase I trial of anemia drug compound PRS-080
By PBR Staff Writer
Germany-based biotechnology firm Pieris has started a Phase I clinical trial of PRS-080, an anti-hepcidin Anticalin therapeutic protein designed to treat anemia.
Automation > IT & Software > News
Navidea forms Macrophage Therapeutics business unit to explore Therapeutic applications of Manocept
Navidea Biopharmaceuticals announced the formation of a new business unit, Macrophage Therapeutics, to further explore therapeutic applications for the Manocept platform.
Automation > IT & Software > News
Vital Connect, Medidata partner to enhance clinical trials with continuous Vital sign monitoring
Vital Connect announced that its FDA-cleared wearable biosensor, HealthPatch MD, is now available for use in clinical trials in partnership with Medidata (MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences.
Automation > IT & Software > News
FDA accepts filing of Aprecia's NDA for first product using ZipDose technology
By PBR Staff Writer
The US Food and Drug Administration (FDA) has accepted for filing Aprecia Pharmaceuticals' new drug application (NDA) for the first product using its ZipDose technology, a formulation platform that allows medicine to swiftly disperse in the patient’s mouth with a sip of water or other liquid.
Automation > IT & Software > News
Lilly, Anthem and HealthCore partner to improve health outcomes
By PBR Staff Writer
Eli Lilly and Company, Anthem and HealthCore have formed a five-year, real-world evidence research collaboration to improve health outcomes for patients.
Automation > IT & Software > News
Novartis reports positive clinical data from leukemia drug CTL019 in children and young adults
Findings from continued clinical studies of investigational chimeric antigen receptor (CAR) therapy, CTL019, demonstrate its potential role in the treatment of certain types of lymphocytic leukemia.
Automation > IT & Software > News
OncoSec reports positive six-month results from Phase II trial of melanoma drug
By PBR Staff Writer
US-based OncoSec Medical has reported positive top-line six-month results from the first Phase II trial of its investigational intratumoral plasmid IL-12 electroporation (pIL-12 EP) monotherapy (ImmunoPulse IL-12) to treat patients with stage III and IV metastatic melanoma.
Automation > IT & Software > News
Basilea launches Zevtera in Germany
By PBR Staff Writer
Switzerland-based Basilea Pharmaceutica has launched its broad-spectrum antibiotic, Zevtera (ceftobiprole medocaril) in Germany to support the treatment of bacterial lung infections.
Automation > IT & Software > News
Foundation Medicine and Flatiron Health to develop data platform to accelerate Precision Medicine for Cancer
Foundation Medicine, and Flatiron Health announced a strategic collaboration to develop a unique, proprietary cloud-based information platform combining genomic and clinical treatment and outcomes data to significantly advance the field of precision medicine for cancer.
Automation > IT & Software > News
Unum Therapeutics begins Phase I trial of ATTCK20 combination therapy
By PBR Staff Writer
US-based Unum Therapeutics has started a Phase I trial designed to evaluate the feasibility, safety and potential efficacy of infusing the ATTCK20 combination therapy in patients with B-cell malignancies and persistent disease following standard therapy.
Automation > IT & Software > News
CareNet joins Indegene partnership network to accelerate growth in Japanese markets
Indegene, a leading global provider of clinical, commercial, and marketing solutions to global life science, pharmaceutical, and healthcare organizations, announced a partnership with Tokyo-based pharmaceutical sales support and marketing research services company CareNet, to mutually expand presence in Japan.
Automation > IT & Software > News
91-105 of 1566 results